Free access supported by contributions and sponsoring — share your knowledge or support us financially
Search / Compare / Validate Lab equipment & Methods

Market Availability & Pricing

The ab8805 antibody is commercially available from Abcam and can be purchased through authorized distributors. Based on the information provided, the typical price range for a 200 µL size is around £472.50, as listed on the Fisher Scientific UK website. For customers in the United States, the pricing may vary, so it's recommended to check Abcam's official website or contact authorized distributors for the most current pricing information.

Need Operating Instructions, SDS, or distributor details? Just ask our AI Agent.

Is this product still available?

Get pricing insights and sourcing options

The spelling variants listed below correspond to different ways the product may be referred to in scientific literature.
These variants have been automatically detected by our extraction engine, which groups similar formulations based on semantic similarity.

Product FAQ

410 protocols using «ab8805»

1

Protein Expression Analysis of FLT3, AKT, and Cell Cycle Regulators

2025
The cells were lysed in the presence of protease and phosphatase inhibitors (Ovibion, China), and the whole-cell lysates were subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. The proteins were then transferred to polyvinylidene difluoride membranes (0.45 μM, Merk Millipore Ltd., Tullagreen, Carrigtwohill, Co. Cork Ireland) and westen blot with antibodies against FLT3 (ab245116; Abcam, Cambridge, MA, USA), AKT (ab8805; Abcam), p21 (AF6290), P-p21 (DF4570), CDK2 (AF6237), PI3K (tyr458), CyclinA (AF0142; Affinity Biosciences, Zhenjiang, Jiangsu, China), p53 (9286; Cell signaling Technology, Danvers, MA, USA), β-actin (66009-1-Ig; Proteintech, Rosemont, IL, USA). Western blotting was repeated at least three times, and a representative blot is shown.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

Comprehensive Protein Expression Analysis

2025
The levels of MAF1, CUL2, CD31, GFAP, caspase-3, RIG-I, IRF-3, p62, LC3B, AKT, p-AKT, p-mTOR, and PTEN protein expression were evaluated by western blotting. The protein concentrations in cell and tissue extracts were determined using a Pierce BCA Protein Assay kit (no. 23227; Thermo Scientific, Waltham, MA, USA).
An aliquot of protein from each sample was separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) performed at 120 V. The separated protein bands were transferred onto polyvinylidene fluoride (PVDF) membranes, which were subsequently washed with Tween-20: TBS at 1:1000 for 5 min and then blocked with 5% powdered skimmed milk at 4 ℃ overnight. Next, the membranes were incubated for 1 h with primary antibodies against MAF1, CUL2, CD31 (1:2000, ab222781, Abcam, Cambridge, MA, USA), GFAP (1:1000, ab279291), caspase-3 (1:2000, ab184787), RIG-I (1:1000, ab180675), IRF-3 (1:1000, ab238521), p62 (1:2000, PB0458), LC3B (1:1000, PA01524), AKT (1:500, ab8805), p-AKT (1:500, ab38449), p-mTOR (1:2000, ab109268), PTEN, and GAPDH (1:5000; ab8245) and subsequently incubated with a secondary antibody [horseradish peroxidase (HRP)-labeled goat anti-rabbit IgG]. The PVDF membranes were then incubated with electrogenerated chemiluminescence (ECL) solution (ECL808-25, Biomiga, San Diego, CA, USA) for 1 min and exposed to X-ray film. The net density value of each band was calculated using Image-Pro Plus 6.0 software, with GAPDH serving as an internal reference band. All experiments were repeated three times.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

Protein Extraction and Western Blot Analysis

2025
Protein extraction utilized RIPA lysis buffer (Beyotime, Shanghai, China) supplemented with protease inhibitors. Protein concentrations were measured using the BCA kit (Beyotime). Subsequently, 30 μg of protein was subjected to 10% SDS-PAGE and subsequently transferred to PVDF membranes (Millipore, Billerica, CA, USA). Membranes were blocked using 5% nonfat dried milk for 2 h, followed by overnight incubation at 4°C with primary antibodies targeting FOXK1 (ab18196, 1:2000, Abcam), FAK (ab40479, 1:2000, Abcam), AKT (ab8805, 1:2000, Abcam), p-AKT (ab38449, 1:1000, Abcam), E-cadherin (ab 40772, 1:5000, Abcam), N-cadherin (ab76011, 1:5000, Abcam), vimentin (ab8978, 1:5000, Abcam), and GAPDH (ab8245, 1:5000, Abcam). HRP-conjugated secondary antibodies (Boster) were utilized for 2 h at room temperature. Proteins were detected using an enhanced chemiluminescence kit (Beyotime), and ImageJ software was used to quantify the protein expression levels.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

Quantification of mTOR Pathway Proteins

2025
All protein levels related to the mTOR pathway (such as mTOR, p-mTOR, p70/S6K, p-p70/S6K, Akt, and p-Akt) were determined by Western blot and selected the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal reference protein. After cutting the intervertebral disc into pieces, radioimmunoprecipitation (RIPA) lysis buffer was used to extract the total cellular protein; then, the protein was quantified by the bicinchoninic acid (BCA) method. Separated proteins to 20 μg per hole by 10% sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-PAGE), then transferred to polyvinylidene difluoride (PVDF) membranes. The current study used 5% non-fat milk with tris buffered saline with tween (TBST) to block the membranes for 2 hr. Then the membranes were incubated overnight at 4 °C with different primary antibodies against mTOR, p70/S6K, p-p70/S6K, Akt (Abcam, ab8805, 1:1000), p-Akt (Abcam, ab81283, 1:500) and p-mTOR (Abcam, ab84400, 1:500). After washing the membranes three times with TBST, they were incubated with horse-radish peroxidase-conjugated secondary antibodies for onehour. The membranes were developed using an enhanced ECL kit (Beyotime, China). The densitometric quantification of the western blot bands was analyzed using Image J software (Bethesda, MD, U.S.A.).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

Protein Extraction and Western Blot Analysis

2025
RIPA lysis buffer supplemented with phosphatase and protease inhibitors was used to isolate total protein. The proteins were transferred to polyvinylidene fluoride membranes following separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Next, primary antibodies [RGS4, ab308160, 1:1500, Abcam; focal adhesion kinase (FAK), ab40794, 1:2000, Abcam; p-FAK, ab81298, 1:1500, Abcam; phosphatidyl-inositol-3-kinase (PI3K), ab302958, 1:1500, Abcam; p-PI3K, ab182651, 1:200, Abcam; protein kinase B (AKT), ab8805, 1:500, Abcam; p-AKT, ab38449, 1:1500, Abcam; E-cadherin, ab40772, 1:1500, Abcam; N-cadherin, ab76011, 1:5000, Abcam; vimentin, ab20346, 1:1500, Abcam; β-actin, ab8227, 1:2000, Abcam] were used to nurture membranes. After incubation with the primary antibody, secondary antibodies were used to nurture membranes for 2 hours.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

Top 5 protocols citing «ab8805»

1

Immunohistochemical Analysis of p-Akt and CIP2A in HCC

Paraffin-embedded HCC tissue sections (4-μm) on poly-1-lysine-coated slides were deparaffinized and rinsed with 10 mM Tris-HCl (pH 7.4) and 150 mM sodium chloride. Peroxidase was quenched with methanol and 3% hydrogen peroxide. Slides were then placed in 10 mM citrate buffer (pH 6.0) at 100 °C for 20 min in a pressurized heating chamber. After incubation with 1 : 200 dilution of p-Akt1/2/3 (Thr 308)-R antibody (ab8805, Abcam, Cambridge, UK) and with 1 : 100 dilution of CIP2A antibody (ab84547, Abcam) for 1 h at room temperature, slides were thoroughly washed three times with PBS. Bound antibodies were detected using the EnVision Detection Systems Peroxidase/DAB, Rabbit/Mouse kit (Dako, Glostrup, Denmark). The slides were then counterstained with hematoxylin. Paraffin-embedded sections of mouse kidney tissue and human colon carcinoma were used as positive controls for p-Akt1/2/3 and CIP-2A, respectively, as described in the datasheet from the manufacturer. Negative controls had the primary antibody replaced by PBS. The expression of p-Akt1/2/3 and CIP-2A was assessed semiquantitatively based on the intensity of staining by a board certified pathologist. The intensity of staining was scored as negative, weak, moderate and strong.
This study was approved by the ethics committee of the Institutional Review Board of Changhua Christian Hospital. All informed consents from sample donors were in accordance with the Declaration of Helsinki and were obtained at the time of their donation.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

Clusterin Regulation in Hepatocellular Carcinoma

Cell lines and culture. Bel7402, Bel7404, and SMMC7721 cells (human hepatocellular carcinoma cell lines) were cultured in RPMI-1640 (Thermo Fisher Scientific, Shanghai, China) supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, and 10% fetal bovine serum. The cells were obtained from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). All cultures were grown at 37°C in a humidified atmosphere containing 5% carbon dioxide13 (link). The OXA (oxaliplatin)-resistant cells, termed Bel7404-OR, were established by incubating Bel7404 cells with OXA13 (link).
Antibodies and reagents. The antibodies used in this study included an antibody against clusterin (#42143), which was obtained from Cell Signaling Technology (Danvers, MA, USA), and antibodies against GADD45a (ab180768), AKT1 (ab18206), AKT (ab8805), Bcl-2 (ab32124) and Bax (ab32503), which were obtained from Abcam (Cambridge, UK). The PI3-kinase inhibitor (LY294002) (ab120243) was purchased from Abcam (Cambridge, UK).
IHC and histopathological analyses. Human hepatocellular carcinoma tissue arrays were obtained from Shanghai Biochip Company Ltd. (Shanghai, China). HCC tissues were obtained from 105 HCC patients undergoing complete surgical resection between January 2007 and November 2009. All patients were followed up until September 2013. None of the patients received radiotherapy or chemotherapy before surgery, and none of them had multiple cancers in other organs.
The tissue microarray was deparaffinized, rehydrated through graded alcohol series, washed with Tris-buffered saline, and processed using a streptavidin-biotin-peroxidase complex method. The tissue microarray was incubated with mouse anti-Clusterin (1:200, Cell Signaling Technology Danvers, MA, USA) overnight at 4°C, followed by incubation with horseradish peroxidase-conjugated secondary antibody. Next, the tissue microarray was assessed by two pathologists who were blinded to the clinical and pathologic information. The staining intensity of the tumor tissues was scored as 0(negative), 1+ (weak), 2+ (moderate) or 3+ (strong), while the staining extent was scored as 0 (<10%), 1+ (10%-25%), 2+ (26%-50%) or 3+ (>50%)15 (link), 16 (link). The product of staining intensity by the staining extent was defined as the final staining score which was classified as negativity (score 0-3) and positivity (score 4-9)17 (link).
Plasmid construction and transfection, cell viability and apoptosis assays. Bel7404 cells stably transfected with the pIRES2-EGFP/sCLU and pIRES2-EGFP vectors were termed Bel7404-sCLUhigh and Bel7404-vec, respectively. Bel7402 or SMMC7721 cells stably transfected with sCLU shRNA (CLU-4) or Sc vectors were termed Bel7402-sCLUlow, Bel7402-vec, SMMC7721-sCLUlow or SMMC7721-vec. The Gadd45a expression vector was constructed and termed pcDNA3.1-Gadd45a-His. The plasmids were transfected into Bel7402 and SMMC7721 cells and were termed as Bel7402-Gadd45a and SMMC7721-Gadd45a, respectively. All these methods were described previously13 (link), 14 (link).
Western blot analysis for protein expression. Whole proteins from cultured HCC cells were extracted using a protein extraction kit (Beyotime, Shanghai, China). In total, 50 µg of proteins was resolved on an 8% SDS-PAGE gel and was transferred to a PVDF membrane (Millipore). Non-specific binding sites in the membranes were blocked with 1% bovine serum albumin in TBST buffer for 2 h at room temperature before the addition of primary antibodies. Appropriate anti-rabbit, anti-mouse and anti-goat antibodies were used as secondary antibodies for 2 h at 37°C. Protein bands were detected by using an ECL detection kit (Millipore, MA, USA) and protein expression was determined using Quantity One software and was normalized to GAPDH.
Statistical analysis. All data were expressed as the mean ± standard deviation (SD) and were analyzed by SPSS 17.0 software. Quantitative data were analyzed using one-way ANOVA. Survival curves were evaluated using the Kaplan-Meier method and were compared using the log-rank test. A value of p <0.05 was considered significant.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

RNA Extraction and qPCR Analysis

Total RNA was isolated from exponentially growing cells (70% confluence) using RNeasy mini Kit (Qiagen, Netherlands) according to by manufacturer's instruction. Real-time quantitative PCR (qPCR) was also performed to analyse mRNA expression levels [16 (link)]. Primer used for RT-PCR and qPCR are as previously described [81 (link)]. Protein expression was analysed using western blot by using the following antibodies: TFF3 (ab108599, 1:1000, Abcam); phospho-AKT1 S473 (ab66138,1:2000, Abcam); pan-AKT (ab8805, 1:2000, Abcam); β-Actin (sc-47778, 1:10000, Santa Cruz), BCL-2 (sc-509, 1:5000, Santa Cruz), Bax (sc-70407, 1:5000, Santa Cruz). The secondary anti-rabbit and anti-mouse horseradish peroxidase (HRP)-conjugated antibodies were purchased from Cell Signaling Technology. Proteins were visualized using the chemiluminescence ECL kit (SuperSignal West Pico substrate; Pierce, Rockford, IL) and read on ImageQuant system LAS500 (GE Healthcare).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

Quantitative Analysis of Cardiovascular Proteins

Tissue samples of the heart and aorta were homogenized, and the Western blot protocol was performed as previously described [68 (link)]. Membranes were incubated overnight with a primary polyclonal rabbit anti-pan-Akt (1:500, Abcam, ab8805), anti-eNOS (1:1000, Abcam, ab5589), anti-p-eNOS (1:1000, Invitrogen, #PA5-35879), anti-NADPH oxidase 4 (1:2000, Abcam, ab154244), and anti-NF-kappaB p65 (1:1000, Abcam, ab16502) antibodies as well as anti-GAPDH (1:5000, Abcam, ab201822) and anti-β-actin (1:2000, Abcam, ab8227) as a loading control. Antibodies were detected using a secondary peroxidase-conjugated goat anti-rabbit antibody (1:5000, Abcam, ab97051) at room temperature for 2 h. The intensity of bands was visualized using the enhanced chemiluminescence system (ECL, Amersham, UK), quantified using a ChemiDocTM Touch Imagine System (Image LabTM Touch software, BioRad, Hercules, CA, USA), and normalized to GAPDH bands for heart and β-actin bands for the aorta.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

Immunohistochemical Evaluation of PTEN/Akt Pathway

Immunohistochemistry was performed on paraffin sections of human biopsy specimens or Mongolian gerbil gastric tissues using anti-PTEN (ab31392; 1:150 [biopsy], 1:800 [gastric tissues]), anti-p-PTEN (Ser380/Thr382/383) (ab47332; 1:800 [biopsy], 1:1000 [gastric tissues]), anti-Akt (ab8805; 1:400), anti-p-Akt (Ser473) (ab66138; 1:400), anti-p-Akt (Thr308) (ab38449; 1:200), anti-Bad (ab32445; 1:1000), and anti-p-Bad (Ser136) (ab28824; 1:1000) antibodies (Abcam, Cambridge, UK) following previously described methods [6 (link)-9 (link), 21 (link)], the specificity of the staining of different antibodies was evaluated by corresponding blocking peptides, and the negative control sections were just incubated with PBS without the primary antibodies. The stained sections were chosen, reviewed, and scored from five randomly selected high power fields (40× objective lens) by two pathologists blinded to the histopathologic data. Grading discrepancies were re-reviewed and discussed to obtain a final score. Epithelial cells with yellow or brown staining in the nucleus and/or cytoplasm was defined as positive for immunoreactivity. The percentage of immunoreactive cells from 100 cells in each field were averaged from the five fields and scored as follows: 0 < 5.0% immunoreactive; 1 = 5.1–25.0%; 2 = 25.1–50.0%; 3 = 50.1–75.0%; and 4 > 75.0%. Moreover, the staining intensity was also semi-quantitatively assessed as 0 = no staining; 1 = weak staining; 2 = moderate staining; and 3 = strong staining. The overall protein expression level was then reported as a grade as calculated from an integral score of the “area × intensity” as follows: grade 1 = score 0–2 (negative); grade 2 = score 3–5 (weakly positive); grade 3 = score 6–8 (moderately positive); and grade 4 = score 9–12 (strongly positive).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Find protocols
2. Find best products for an experiment
3. Validate product use from papers
4. Check Product Compatibility
5. Ask a technical question
Want to copy this response? Upgrade to Premium to unlock copy/paste and export options.